Oligodendrocytes: biology and pathology
Open accessThe DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Abstract
Oligodendrocytes are the myelinating cells of the central nervous system (CNS). They are the end product of a cell lineage which has to undergo a complex and precisely timed program of proliferation, migration, differentiation, and myelination to finally produce the insulating sheath of axons. Due to this complex differentiation program, and due to their unique metabolism/physiology, oligodendrocytes count among the most vulnerable cells of the CNS. In this review, we first describe the different steps eventually culminating in the formation of mature oligodendrocytes and myelin sheaths, as they were revealed by studies in rodents. We will then show differences and similarities of human oligodendrocyte development. Finally, we will lay out the different pathways leading to oligodendrocyte and myelin loss in human CNS diseases, and we will reveal the different principles leading to the restoration of myelin sheaths or to a failure to do so.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Myelin and oligodendrocyte pathology in autoimmune encephalomyelitis, multiple sclerosis, and stroke. a–d Chronic autoimmune encephalomyelitis, induced in DA rat by active sensitization with MOG fusion protein; a massive demyelination is seen in the cerebellar white matter, ×6; b–d oligodendrocytes in different lesion stages of EAE; in the peri-plaque white matter myelin (red) is present and multiple oligodendrocytes with PLP mRNA (black) are seen (b); in the active lesions myelin falls apart, myelin fragments are taken up by macrophages (red granules) and oligodendrocytes are lost (c); in more advanced lesions no macrophages with early myelin degradation products are present; numerous oligodendrocytes re-appear in the lesions, apparently recruited from progenitor cells (black cells), followed by rapid and extensive remyelination; immunocytochemistry for PLP and in situ hybridization for PLP mRNA, ×1000; e–h chronic multiple sclerosis case with extensive remyelination within the CNS; This hemispheric brain section contains 3 active lesions, 4 demyelinated plaques, and 8 remyelinated shadow plaques, ×1.2; f–h double staining for PLP protein (red) and PLP mRNA (black) in one of the active lesions shows a similar pattern as described before in EAE; many oligodendrocytes in the peri-plaque white matter (f); oligodendrocyte loss in the zone of active demyelination (g) and reappearance of oligodendrocytes in the inactive zone, closely adjacent to the zone of activity (h), ×500; i–o myelin changes in the initial stage of a lesion in white matter stroke; LFB shows pale myelin staining (i); the axons, stained with Bielschowsky silver impregnation are largely preserved (k); MAG (l) and CNPase (m) are completely lost from the lesions, while the myelin proteins within the compact sheath (PLP; n) or on the oligodendrocyte surface (MOG; o) are preserved, ×20; p–s acute multiple sclerosis with lesions following a pattern of hypoxia-like tissue injury (Pattern III, [109]). p The section contains areas of initial demyelination (i), early active demyelination (a) and late active or inactive portions (d); q serial section of p, stained by immunocytochemistry for PLP; Only the late active and inactive lesions show loss of PLP; in the active portions (a) a minor loss of PLP reactivity is seen, while in the initial lesions PLP reactivity is the same as in the normal appearing white matter, ×3; r and s edge of an active lesion showing partial preservation of immunoreactivity for MOG (r), but extensive and complete loss of MAG(s), ×20](https://figures.cochat.ai/paper-figures/777f35f33b804c4caf0983c7191aaa36/oligodendrocytes-biology-and-pathology-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, module 14 was enriched in genes involved in myelination49 and blood-brain barrier,50 consistent with the high enrichment of oligodendrocyte populations in the fiber tracts, and indicated blood-brain barrier changes in the thalamus.”
From SCING: Inference of robust, interpretable gene regulatory networks from single cell and spatial transcriptomics (2023) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“Oligodendrocytes have a high metabolic rate and must produce large amounts of membranes and protein, particularly during myelination (Bradl & Lassmann, 2010).”
From Brain structure, working memory and response inhibition in childhood leukemia survivors (2017) · cites this paper as Bradl & Lassmann, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Regional Development of the Brain in Early Life
(1968) · Archives of Disease in Childhood · doi:10.1136/adc.43.229.388 · Cited by 2,090
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Ruiter, A. M., Meilof, J. F., Somanje-Bolweg, R. R. J., van Gorsel, E., & Kalkers, N. F. (2017) · Case Reports in Neurology · doi:10.1159/000455942 · Cited by 1,762
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Interneuron Migration from Basal Forebrain to Neocortex: Dependence on Dlx Genes
Anderson, S. A., Eisenstat, D. D., Shi, L., & Rubenstein, J. L. R. (1997) · Science · doi:10.1126/science.278.5337.474 · Cited by 1,462
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citation
Research works printed but not linked: 1
- Schlesinger H Zur Frage der akuten Multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter Arb Neurol Inst (Wien) 1909 17 410 432
Cited by
Items 901–943 of 943
Preclinical gene therapy using recombinant AAV vectors in mouse models of two human diseases
Günes, Y. Ö. (2022) · theses.fr (ABES) · doi:10.70675/52c9a808z1652z42c4zae82zc812b95f1723 · Cited by 1
Study of the normal and pathological ageing of cortico-cortical fiber bundles by diffusion MRI
Vindas, N. (2024) · theses.fr (ABES) · doi:10.70675/5166708az37d4z4446za4b4ze88c8e1b8a49
Nguyen, H. (2024) · theses.fr (ABES) · doi:10.70675/c70cdfa2ze652z4a28zaa4ez777acef97d0e · Cited by 1
Etude des effets thérapeutiques de la protéine X du virus Borna chez la souris SOD1G93A
Tournezy, J. (2024) · theses.fr (ABES) · doi:10.70675/6679c9cez7694z4a71z84a3za0e24b70e3eb
Maladie de Huntington : huntingtine, connectivité neuronale et métabolisme oxydatif
Capellano, L. (2025) · theses.fr (ABES) · doi:10.70675/dd0b8f65z490fz446fz8d1azd0dd5619a044
Gaitán-Salvatella, Í., Iida, A. T., Álvarez-Pérez, M. A., & Marichi-Rodríguez, F. J. (2026) · Odovtos - International Journal of Dental Sciences · doi:10.15517/xbaew314 · Cited by 1
“Recent advances in regenerative research have focused on identifying stem cells capable of differentiating into oligodendrocytes and cultivating them in three-dimensional models for therapeutic applications (39, 40).”
Wasolua, T. T., Bommersbach, T. J., McIntyre, R. S., & Rhee, T. G. (2026) · Research Square · doi:10.21203/rs.3.rs-9827580/v1
“113,114 The combination of direct NMDAR blockade on oligodendrocytes and indirect oxidative injury from chronic high-dose exposure may synergistically compromise white matter integrity, producing microstructural abnormalities detectable by neuroimaging.”
Duan, J., Fu, Q., Huo, Y., Wang, C., Shen, Y., Zhong, M., Ma, X., & Liu, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1860628 · Cited by 1
“Oligodendrocyte precursor cell (OPC)-to-oligodendrocyte differentiation is characterized as a sequential fi ve-stage process: proliferation, migration, adhesion to axons, maturation with synthesis of myelin structural proteins (PLP1, MBP, MOG), and axonal myelin wrapping (37).”
Wiegand, T. L. T., Rubinski, A., Jung, L., Franzmeier, N., Arciniega, H., Ravanfar, P., Dewenter, A., Alosco, M. L., Tripodis, Y., Su, Y., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71503
“43,44 Damage or dysregulation of oligodendrocytes presents a risk factor for neurodegeneration.”
Hsieh, C. C., Tsou, Y., Huang, N., Chen, T., Li, S., Chang, C.-W., Lin, W.-X., Tung, S.-Y., Chern, Y., Chen, Y. L., et al. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01269-4 · Cited by 1
“Central nervous system (CNS) myelination is an essential and highly orchestrated process involving the proliferation, differentiation, and maturation of a type of glial cells called oligodendrocytes (OLs) [32].”
Izagirre‐Urizar, L., Mora-Huerta, L., Soler-Sáez, I., Morales‐Gallel, R., Masson, M. L. P., Ulloa-Navas, M. J., Chara, J. C., Calovi, S., Deboux, C., Merino‐Cacho, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74488-w · Cited by 5
Yang, H., Park, Y. H., Kim, D. J. H., Lee, A., Park, M., Koh, E., & Lee, G. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04214-z
“This high metabolic demand renders them particularly susceptible to mitochondrial dysfunction, metabolic imbalance, and oxidative stress [11].”
Chang, M., Li, R., Stephan, M., Schmitt, A., Falkai, P., & Rossner, M. J. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1837159
“Myelination not only facilitates rapid and efficient transmission of action potentials along the axons (Bradl and Lassmann, 2010) but also regulates the development and plasticity of neuronal networks (Takahashi et al., 2011).”
Role of E3 Ubiquitin Ligases in Oligodendrocyte Health and Disease
Mabb, A. M., Pyaram, D. N., & Samanta, J. (2026) · ASN NEURO · doi:10.1080/17590914.2026.2682220
“Specific roles for OLs include myelinating axons, providing key energetic metabolic support, and regulating neuroin-flammatory responses (Bradl & Lassmann, 2010).”
Ploughman, M., Cattaneo, D., Marazzini, F., Bray, N. W., & Fritz, N. E. (2026) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-026-01501-6
“Myelination was believed to be regulated by two key processes: (1) contact-mediated signaling from cell surface molecules [9]; and (2) self-regulation by oligodendrocytes, the myelinating cells that wrap axons and permit efficient action potential propagation [10, 11].”
Lv, X., Li, C. G., Zhang, Y., Luo, Q., Gao, T., Deng, H., Li, H., Peng, X., Shen, J., Liu, S., et al. (2026) · Toxics · doi:10.3390/toxics14070605
“Oligodendrocytes are the myelinating cells of the CNS, and their development is tightly regulated by the transcription factor OLIG2 [28,29].”
Zeng, W., Yang, X., & Xu, Y. (2026) · Genes · doi:10.3390/genes17070813
“Oligodendrocyte-related signals may be relevant to myelination and neural conduction, while astrocyte-related signals may reflect metabolic support, synaptic homeostasis, and neuroimmune regulation [42,43].”
Wawrzyniak, A., Żuryń, A., Cassano, T., Pawlikowska-Pawlęga, B., Kłosowicz, M., & Balawender, K. (2026) · Research Square · doi:10.21203/rs.3.rs-10120283/v1
Meijer, M., Fu, M. P., Navarro‐Delgado, E. I., Engelbrecht, H.-R., Turecki, G., Chan, M. H.-M., & Kobor, M. S. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101316 · Cited by 1
“…receive and send information; glial cells have a supporting role in the central nervous system: microglia and astrocytes are important effector cells in the central immune system (Greenhalgh et al., 2020), whereas the main role of oligodendrocytes is to myelinate neurons (Bradl and Lassmann, 2010).”
Khodanovich, M. Y., Светлик, М. В., Kamaeva, D. A., Usova, A. V., Anan’ina, T. V., Wasserlauf, I. E., Shadrina, M., Pashkevich, V., Moshkina, M., Obukhovskaya, V. B., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14081691
TDP-43 dysfunction destabilizes glial homeostatic identity in ALS/FTD
Dale, A. E., & Sattler, R. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150618
Killam, B. Y., Knol, M. J., Fradejas‐Villar, N., Chillon, T. S., Ruijter, G. J. G., Bonte, R., Abdulwahab, F., Aldhalaan, H., AlFaifi, A. Y., Alkuraya, F. S., et al. (2026) · Genetics in Medicine · doi:10.1016/j.gim.2026.102684 · Cited by 1
Aydın, S. A. V., & Diniz, G. (2026) · Springer eBooks · doi:10.1007/978-3-032-23963-1_23
Gromadzka, G., Kąkol, M., Klimkiewicz, M., & Bendykowska, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167507
“In this inflammatory milieu, oligodendrocytes are particularly vulnerable because of the high metabolic demands associated with myelin synthesis and maintenance, combined with their relatively limited antioxidant reserve [165,166].”
Rasile, M., Smith, K. L., & Matteoli, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-24078-2.00031-0
Maghareh, M., Carrera, E. M., Cicala, D. S., Roknuzzaman, A. S. M., Sarker, R., Geldenhuys, W. J., & Huber, J. D. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1838011
“Excess iron catalyzes the Fenton reaction, leading to sustained production of reactive oxygen species (ROS) and lipid peroxidation, thereby amplifying oxidative damage (Bradl and Lassmann, 2010; Kugler et al., 2021; Kenny et al., 2019).”
InfluentialHedayatpour, M. J., Ailani, R., Williamson, M. R., Pedersen, S. E., Pautler, R. G., Nicot-Cartsonis, M. S., Adler, A. C., Kheradmand, F., Deneen, B., Harmancı, A. S., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115991
Tao, J., Wang, G., Jiang, G., & Feng, W. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1885261
“Oligodendrocytes are also plausible targets because myelination and axonal support impose high metabolic demands, and remyelination failure is a major repair bottleneck after SCI (Bradl and Lassmann, 2010; Plemel et al., 2014).”
Li, R., Lu, J., Zhang, C., Zhang, X., Wang, M., Zhang, P., Yang, K., Fang, H., Gao, Y., Mohamed, K., et al. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1820913
Xu, M., Jiang, C., Yan, X., He, J., Zhang, S., Cheng, L., Han, W., & Jiang, L. (2026) · Research Square · doi:10.21203/rs.3.rs-10661255/v1
Nikiforova, E. V., Vetlugina, А., Konovalova, S. P., Sysoev, Y. I., & Евгеньевич, М. П. (2026) · Cells · doi:10.3390/cells15181667
“This pronounced vulnerability of oligodendrocytes is rooted in their metabolic peculiarities [35]: high metabolic activity, high iron content serving as a cofactor for myelination enzymes, and low antioxidant capacity [36,37].”
Mahawar, U., Fulani, R., Mockenhaupt, K., Saha, S., Farooq, F., Afshari, F. S., Manam, S., Sato‐Bigbee, C., Fuss, B., Dupree, J. L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.23.753788
“In the field of OLG biology, much attention has focused on OLG differentiation [25-27], the importance of the myelin proteins[4, 28-30], mechanisms by which OLGs and neurons communicate during myelination[31], and the contributions of astrocytes and microglia to myelination [32].”
A Fractional Hodgkin–Huxley–Lotka–Volterra Model of Neuronal Synchronized Electromechanics
Moore, A. H., & Drapaca, C. S. (2026) · Fractal and Fractional · doi:10.3390/fractalfract10100677
Neurotoxic effects of mercury: in vitro and in vivo studies
Gaur, K., & Siddique, Y. H. (2026) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2026.2747093
Chung, C., Kim, M. J., Field, G., Pilarinos, K., Kharitonova, E. K., Campbell, N. B., Shi, M., Gabel, C. V., Orofino, J., & Zeldich, E. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150601 · Cited by 3
Laminin Expression and Function in the Central Nervous System
Xu, L., Yuan, S., & Yao, Y. (2026) · Proteoglycan Research · doi:10.1002/pgr2.70058
Isolation and Culture of Oligodendrocyte Lineage Cells from Rodent Brains
Kim, H., & Choi, J. Y. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5671-6_1
Introduction to Neuroimmunology
Coyle, P. K. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-860-7_1
Investigation of myelin membrane adhesion and compaction in the central nervous system
Bakhti, M. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3712
Regenerative Potential of NG2 Cells
Mangin, J. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4899-7399-3_7
Metadata
- Authors
- Bradl, M., & Lassmann, H.
- Affiliations
- Medical University of Vienna (AT)
- University of Vienna (AT)
- Corresponding author
- Bradl, Monika
- Venue
- Acta Neuropathologica
- Published
- 2009-10-22
- Volume
- 119
- Issue
- 1
- Pages
- 37-53
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2799635
- OpenAlex
- W2018558728
- Cited by
- 933
- References
- 221
- Citations by year
- 2026: 66 · 2025: 67 · 2024: 85 · 2023: 69 · 2022: 74 · 2021: 84 · 2020: 61 · 2019: 72 · 2018: 50 · 2017: 46 · 2016: 44 · 2015: 39 · 2014: 41 · 2013: 51 · 2012: 28
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Austrian Science Fund (P 19854)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- oligodendrocytes, myelination, myelin sheath, oligodendrocyte lineage, oligodendrocyte differentiation, demyelination, demyelinating disease, central nervous system
- MeSH terms
- Animals, Central Nervous System, Central Nervous System Diseases, Humans, Myelin Sheath, Nerve Fibers, Myelinated, Oligodendroglia, Species Specificity, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.